From the Centers for Disease Control and Prevention. Update: Fatal and severe liver injuries associated with Rifampin and Pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States, 2001

JAMA. 2001 Sep 26;286(12):1445-6.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Antitubercular Agents / adverse effects*
  • Antitubercular Agents / therapeutic use
  • Chemical and Drug Induced Liver Injury / etiology*
  • Chemical and Drug Induced Liver Injury / mortality
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Middle Aged
  • Practice Guidelines as Topic
  • Pyrazinamide / adverse effects*
  • Pyrazinamide / therapeutic use
  • Rifampin / adverse effects*
  • Rifampin / therapeutic use
  • Tuberculosis / drug therapy*

Substances

  • Antitubercular Agents
  • Pyrazinamide
  • Rifampin